Prevention of kernicterus in South Asia: Role of neonatal G6PD deficiency and its identification

Indian Journal of Pediatrics

Volumn 81, Issue 6, 2014, Pages 599-607

  Arain, Yassar H ^a   Bhutani, Vinod K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deafness; Disability; G6PD deficiency; Hyperbilirubinemia; Impairment; Jaundice; Mortality; Neonatal

Indexed keywords

CLINICAL FEATURE; GESTATIONAL AGE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HIGH RISK INFANT; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; LIVE BIRTH; MALARIA; NEWBORN SCREENING; PREVALENCE; PUBLIC HEALTH SERVICE; REVIEW; SOUTH ASIA; ASIA; COMPLICATION; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; MALE; NEWBORN;

ASIA; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INFANT, NEWBORN; KERNICTERUS; MALE; NEONATAL SCREENING;

EID: 84902134475     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-014-1410-y     Document Type: Review

References (51)

1. Kaplan M, Bromiker R, Hammerman C. Severe neonatal hyperbilirubinemia and kernicterus: Are these still problems in the third millennium? Neonatology. 2011;100:354-62.
2. Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: Incidence and impairment estimates for 2010 at regional andglobal levels. Pediatr Res. 2013;74:86-100.
3. Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, et al; Initial clinical testing evaluation and risk assessment for universal screening for Hyperbilirubinemia Study Group. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013;162:477-82.
4. Weng YH, Chiu YW, Cheng SW, Hsieh MY. Risk assessment for adverse outcome in term and late preterm neonates with bilirubin values of 20 mg/dL or more. Am J Perinatol. 2011;28:405-12.
5. Newman T, Xiong B, Gonzales V, Escobar G. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140-7.
6. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in termand near-terminfants. Pediatrics. 2008;121:e170-9.
7. Dennery PA, Seidman DS, Steveson DK. Neonatal hyperbilirubinemia. N Engl J Med. 2001;344:581-90.
8. Bhutani VK, Johnson LH, Maisels MJ, Newman TB, Phibbs C, Stark AR, et al. Kernicterus: Epidemiological strategies for its prevention through systems-based approaches. J Perinatol. 2004;24:650-62. (Pubitemid 39405878)
9. Bhutani VK. Jaundice due to glucose-6-phosphate dehydrogenase deficiency. NeoReviews. 2012;13:e166-77.
10. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175:587-90. (Pubitemid 44439718)
11. Manning D, Todd P, Maxwell M, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. 2007;92:F342-6. (Pubitemid 47436215)
12. IDEO. Human-centered design toolkit: An open-source toolkit to inspire new solutions in the developing world. IDEO, 2011.
13. Shapiro SM. Hyperbilirubinemia and therisk for brain injury. In: Perlman J, Polin R, eds. Neurology: Neonatology Questions and Controversies. Philadelphia: Saunders Elsevier; 2008. p. 195-209.
14. Bhutani VK, Wong RJ. Bilirubin neurotoxicity in preterm infants: Risk and prevention. J Clin Neonatol. 2013;2:61-9.
15. Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage-mechanisms and management approaches. N Engl JMed. 2013;369:2021-30.
16. Maisels MJ, Bhutani VK, Bogen D, Newman T, Stark A, Watchko JF. Hyperbilirubinemia in the newborn infant or = 35 weeks' gestation: An update with clarifications. Pediatrics. 2009;124:1193-8.
17. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64-74.
18. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267-78.
19. Luzzatto L, Metha A, Vulliamy T. Glucose 6-phosphate dehydrogenase deficiency. In: Scriver C, Beaudet A, Sly W, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001. p. 4517-53.
20. Kaplan M, Rubaltelli TM, Hammerman C, Vilei MT, Leiter C, Abramov A, et al. Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiency. J Pediatr. 1996;128:695-7. (Pubitemid 26137731)
21. Lin Z, Fontaine J, Watchko JF. Coexpression of gene polymorphisms involved in bilirubin production and metabolism. Pediatrics. 2008;122:e156-62.
22. Luzzatto L, Malaria NN. Protecting against bad air. Science. 2001;293:442-3.
23. Luzzatto L. Glucose 6-phosphate dehydrogenase deficiency: From genotype to phenotype. Haematologica. 2006;91:1303-6. (Pubitemid 44574287)
24. Howes R, Piel F, Patil A, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: A geostatistical model-based map. PLoS Med. 2012;9:e1001339.
25. Watchko JF, Kaplan M, Stark AR, Stevenson DK, Bhutani VK. Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? J Perinatol. 2013;33:499-504.
26. Leslie T, Moiz B, Mohammad N, Amanzai O, Ur Rasheed H, Jan S, et al. Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: Implications for treatment policy in the region. Malar J. 2013;12:230.
27. Saha N, Tay JSH. Genetic studies among the Nagas and Hmars of eastern India. Am J Phys Anthropol. 1990;82:101-12. (Pubitemid 20196755)
28. Ramadevi R, Savithri HS, Devi AR, Bittles AH, Rao NA. An unusual distribution of glucose-6-phosphate dehydrogenase deficiency of south Indian newborn popluation. Indian J Biochem Biophys. 1994;31:358-60.
29. Dash S, Chhanhimi L, Chhakchhuak L, Zomawaia E. Screening for haemoglobinopathies and G6PD deficiency among the Mizos of Mizoram: A preliminary study. Indian J Pathol Microbiol. 2005;48:17-8.
30. Sharma M, Dass J, Dhingra B, Saxena R. G6PD deficiency in females screened at tertiary care hospital. Indian J Pathol Microbiol. 2011;54:850-1.
31. Balgir RS. Community expansion and gene geography of sickle cell trait and G6PD deficiency, and natural selection against malaria: Experience from tribal land of India. Cardiovasc Hematol Agents Med Chem. 2012;10:3-13.
32. Bisoi S, Chakraborty S, Chattopadhyay D, Biswat B, Ray S. Glucose-6-phosphate dehydrogenase screening of babies born in a tertiary care hospital in West Bengal. Indian J Public Health. 2012;56:146-8.
33. Matsuoka H, Jichun W, Hirai M, Yoshida S, Arai M, Ishii A, et al. Two cases of glucose-6-phosphate dehydrogenase-deficient Nepalese belonging to the G6PD Mediterranean-type, not India-Pakistan subtype but Mediterranean-Middle East sub-type. J Hum Genet. 2003;48:275-7. (Pubitemid 36759490)
34. Stern MA, Kynoch PA, Lehmann H. Beta-thalassaemia, glucose-6-phosphate- dehydrogenase deficiency, and haemoglobin D-Punjab in Pathans. Lancet. 1968;291:1284-5.
35. Nair H. Neonatal screening program for G6PD deficiency in India: Need and feasibility. Indian Pediatr. 2009;46:1045-9.
36. Bhutani VK. Public policy to prevent severe neonatal hyperbilirubinemia. In: Stevenson DK, Maisels MJ, Watchko JF, eds. Care of the Jaundiced Neonate. New York: McGraw-Hill; 2012. pp. 243-62.
37. Kaplan M, Hammerman C. Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: Biochemical versus genetic technologies. Semin Perinatol. 2011;35:155-61.
38. Abu-Osba YK, Mallouh AA, Hann RW. Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants. J Pediatr. 1989;114:748-52. (Pubitemid 19122968)
39. Gamaleldin R, Iskander I, Seoud I, Aboraya H, Aravkin A, Sampson PD, et al. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics. 2011;128:e925-31.
40. Crosse VM, Meyer TC, Gerrard JW. Kernicterus and prematurity. Arch Dis Child. 1955;30:501-8.
41. Ahlfors C, Amin S, Parker A. Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. J Perinatol. 2009;29:305-9.
42. Trotman H, Henny-Harry C. Factors associated with extreme hyperbilirubinaemia in neonates at the University Hospital of the West Indies. Paediatr Int Child Health. 2012;32:97-101.
43. WHO WG. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989;67:601-11.
44. Padilla CD, Krotoski D, Therrell Jr BL. Newborn screening progress in developing countries - overcoming internal barriers. Semin Perinatol. 2010;34:145-55.
45. Missiou-Tsagaraki S. Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: prevalence among 1,286,000 Greek newborn infants. J Pediatr. 1991;119:293-9.
46. Joseph R, Hoy LY, Gomez JM, Rajdurai VS, Sivasankaran S, Yip YY. Mass newborn screening for glucose-6-phosphate dehydrogenase deficiency in Singapore. Southeast Asian J Trop Med Public Health. 1999;30:70-1.
47. Slusher T, Zipursky A, Bhutani VK. A Global need for affordable neonatal jaundice technologies. Semin Perinatol. 2011;35:185-91.
48. Nair H, Panda R. Quality of maternal health care in India: Has the National Rural Health Mission made a difference? J Glob Health. 2011;1:79-86.
49. Weiss MG, Ramakrishna JR, Somma D. Health-related stigma: Rethinking concepts and interventions. Psychol Health Med. 2006;11:277-87. (Pubitemid 43995592)
50. Solanki KK. Training programmes for developing countries. J Inherit Metab Dis. 2007;30:596-9. (Pubitemid 47377056)
51. WHO. WHO Collaborating Centres. 2013. http://www.who.int/ collaboratingcentres/en/. Accessed on 21 Oct 2013.